SEC Form 4 · accession 0001235802-18-000179
DiaMedica Therapeutics Inc. · DMAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randall Michael Giuffre
Director
Period of report
Dec 11, 2018
Accepted (ET)
Dec 11, 2018 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401040
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Voting Common Shares, no par value per shareF1 | Dec 11, 2018 | P | 11,250 | $4.00 | A | 85,804 | D | |
| Voting Common Shares, no par value per shareF2 | holding | — | — | — | 5,165 | I | See footnote | |
| Voting Common Shares, no par value per share | holding | — | — | — | 21,070 | I | By Spouse | |
| Voting Common Shares, no par value per share | holding | — | — | — | 54,186 | I | By Children |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 36,498 voting common shares held by Michael Giuffre and his wife jointly and 45,160 voting common shares held by Michael Giuffre individually.
- F2These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.